ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin. [electronic resource]
Producer: 20170127Description: 1725-6 p. digitalISSN:- 1432-0584
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Blood-Brain Barrier
- Brain -- diagnostic imaging
- Brentuximab Vedotin
- Female
- Humans
- Immunoconjugates -- pharmacokinetics
- Lymphoma, Large-Cell, Anaplastic -- diagnostic imaging
- Magnetic Resonance Imaging
- Middle Aged
- Positron Emission Tomography Computed Tomography
- Recurrence
- Remission Induction
- Salvage Therapy
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.